1nhaler, a Scotland-based drug delivery device developer, has raised £2 million to develop its unique single-use dry powder inhaler (DPI). Inhalable medicines are already widely used to treat conditions such as asthma, epilepsy, allergies and Parkinson’Read More
Tags :Archangels
Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £4 million to scale up market-testing of its technology platform Cytomos Dielectric Spectroscopy (CDS). The investment round was Read More
Scottish technology firm Bioliberty has secured £2.2 million in funding to develop a unique soft robotic glove which can restore upper limb mobility in patients following a stroke. The funding round was led by Archangels, Read More
PhysioMedics is poised to scale its commercial operations after securing growth capital frominvestors led by Archangels, the world’s longest continually operated business angel syndicate. Theinvestment follows the appointment last year of experienced CEO, Charles Read More
Scottish tech firm Earth Blox has secured £1.5m funding from Archangels to expand its global reach and further develop its no-code Earth Observation (EO) cloud based SaaS. Earth Blox enables users to Read More
Fundraising round supports Reactec’s development of social distancing tech Reactec, the Edinburgh-based tech company that recently launched its innovative SAFE-DISTANCE device to enable social distancing among workers, has completed a further £700,000 round of fundraising Read More
Edinburgh, September 4th 2019 – CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has closed the final part of a £4.5 million equity funding round led Read More